Mahmoud Aljurf Selected Research

Mahmoud Aljurf Research Topics

Disease

41	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 09/2009
38	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 07/2008
35	Leukemia 04/2024 - 08/2008
34	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2023 - 10/2005
32	Neoplasms (Cancer) 04/2024 - 08/2004
27	Aplastic Anemia (Anemia, Hypoplastic) 12/2023 - 09/2009
18	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 11/2010
14	Infections 04/2024 - 01/2010
13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 11/2010
12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2023 - 08/2003
12	Bronchiolitis Obliterans Syndrome 01/2022 - 12/2011
9	Multiple Myeloma 03/2024 - 01/2019
7	Lymphoma (Lymphomas) 12/2022 - 12/2002
6	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 12/2020
5	idiopathic Aplastic anemia 01/2023 - 09/2009
5	T-Cell Lymphoma (Lymphoma, T Cell) 06/2022 - 12/2002
5	COVID-19 01/2022 - 05/2020
5	Chromosome Aberrations (Chromosome Abnormalities) 05/2021 - 07/2008
4	Sickle Cell Anemia (Hemoglobin S Disease) 10/2023 - 04/2016
4	Bone Marrow Failure Disorders 05/2023 - 01/2020
4	Philadelphia Chromosome 04/2023 - 03/2015
4	Infertility (Sterility) 01/2022 - 03/2013
4	Hemoglobinopathies 12/2017 - 01/2011
3	Communicable Diseases (Infectious Diseases) 04/2024 - 01/2022
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2024 - 01/2021
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2023 - 01/2011
3	Virus Diseases (Viral Diseases) 05/2023 - 10/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2022 - 06/2015
3	Pathologic Complete Response 11/2022 - 01/2020
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2022 - 11/2017
3	Fanconi Anemia (Fanconi's Anemia) 01/2020 - 12/2013
2	Nocardia Infections 04/2024 - 01/2022
2	Cytopenia 07/2023 - 05/2020
2	Thalassemia 04/2023 - 04/2016
2	Mycoses (Diseases, Fungus) 04/2023 - 11/2022
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 05/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2022 - 01/2020
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 01/2022
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 11/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2020
2	Thrombotic Microangiopathies 01/2020 - 01/2019
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2018
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 01/2018
2	Immune System Diseases (Immune Disorders) 12/2015 - 01/2011
2	Cytomegalovirus Infections (Inclusion Disease) 01/2015 - 01/2010

Drug/Important Bio-Agent (IBA)

26	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2024 - 10/2013
12	fludarabineIBA 12/2023 - 09/2009
10	Busulfan (Busulfex)FDA Link 10/2023 - 10/2013
8	Tyrosine Kinase InhibitorsIBA 04/2023 - 04/2012
8	Chimeric Antigen ReceptorsIBA 12/2022 - 01/2019
7	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 09/2009
6	AntigensIBA 12/2022 - 08/2008
6	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022 - 11/2010
5	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 01/2019
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 09/2009
4	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2022 - 01/2017
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 01/2019
4	fms-Like Tyrosine Kinase 3IBA 01/2020 - 10/2016
3	Core Binding Factors (Core-Binding Factor)IBA 04/2024 - 01/2020
3	Tacrolimus (Prograf)FDA LinkGeneric 04/2024 - 01/2017
3	AntibodiesIBA 07/2023 - 01/2020
3	SteroidsIBA 02/2020 - 01/2011
3	tisagenlecleucelIBA 12/2019 - 01/2019
3	Calcineurin InhibitorsIBA 01/2019 - 01/2018
3	Filgrastim (Neupogen)FDA Link 11/2017 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 09/2016 - 07/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 09/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 01/2022
2	Bortezomib (Velcade)FDA Link 03/2024 - 01/2022
2	Immunoglobulin G (IgG)IBA 07/2023 - 05/2023
2	Monoclonal AntibodiesIBA 07/2023 - 12/2022
2	AndrogensIBA 05/2023 - 01/2023
2	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2022
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022 - 01/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2022 - 01/2011
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2022 - 12/2002
2	Imatinib Mesylate (Gleevec)FDA Link 09/2021 - 01/2003
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 11/2017
2	Rituximab (Mabthera)FDA Link 01/2020 - 01/2011
2	Alemtuzumab (Campath)FDA Link 01/2020 - 01/2019
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 09/2009
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 08/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2016
2	InterferonsIBA 11/2017 - 06/2014
2	Biomarkers (Surrogate Marker)IBA 09/2016 - 01/2016

Therapy/Procedure

81	Cell Transplantation 04/2024 - 01/2015
76	Transplantation 04/2024 - 11/2010
50	Hematopoietic Stem Cell Transplantation 12/2023 - 08/2003
46	Therapeutics 03/2024 - 07/2008
34	Stem Cell Transplantation 01/2024 - 08/2003
11	Drug Therapy (Chemotherapy) 11/2023 - 12/2002
10	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2024 - 09/2008
9	Homologous Transplantation 01/2023 - 01/2016
5	Immunotherapy 06/2022 - 08/2008
4	Autologous Transplantation 01/2023 - 01/2018
2	Donor Selection 12/2023 - 03/2022
2	Secondary Prevention 10/2023 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 06/2022
2	Activities of Daily Living (ADL) 01/2019 - 01/2019